Chris J. O’Callaghan
机构：Queen's University, Canadian Cancer Trials Group · ORCID：0000-0003-2896-666X
发表论文 202 篇 · 总被引 13933 次 · h-index 41
代表论文
- Preoperative Chemoradiotherapy for Resectable Gastric Cancer (2024 · New England Journal of Medicine · 被引 122)
- Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial (2024 · Neuro-Oncology · 被引 51)
- INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer (2024 · Journal of Clinical Oncology · 被引 23)
- Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial (2024 · Clinical Cancer Research · 被引 20)
- Clonal Hematopoiesis of Indeterminate Potential and its Association with Treatment Outcomes and Adverse Events in Patients with Solid Tumors (2024 · Cancer Research Communications · 被引 15)
- Kinetic Profiling of RAS Mutations With Circulating Tumor DNA in the Canadian Cancer Trials Group CO.26 Trial Suggests the Loss of RAS Mutations in Neo-RAS-Wildtype Metastatic Colorectal Cancer Is Transient (2024 · JCO Precision Oncology · 被引 5)